Matt Miksic is ranked #2281 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

Matt Miksic (Barclays) — Analyst Ratings, Accuracy & Track Record

Q: How accurate are Matt Miksic's stock ratings?

About 34% of Matt's ratings were profitable over a one-year hold, with an average return of -9.3% per rating, measured by 13Foresight from historical prices.

Analyst Tracker/Matt Miksic

BARC

Matt Miksic

Barclays

Wall Street Analyst

★★☆☆☆

#2281

on 13Foresight · ranked by our own returns

32%

Success Rate

-9.4%

Average Return

12 of 38 calls profitable · -12.8% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compare To ⓘ

🔒 5-year track record is Pro. Showing 1-year — upgrade.

📈 Across the calls we could measure, roughly 32% of Matt Miksic's ratings turned a profit when each position was held for 1 year — averaging -9.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

116 Buy 48 Hold 12 Sell

Matt's Stock Coverage 40 ratings · 2026-06-20

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return
BSX Boston Scientific	May 28, 2026	BUY	Strong Buy +72.9% avg upside 38 analysts	$89.00 96.44% Upside	-7.7%
PODD Insulet	May 28, 2026	SELL	Strong Buy +79.0% avg upside 32 analysts	$198.00 35.77% Upside	-4.9%
DXCM Dexcom	May 18, 2026	SELL	Strong Buy +38.6% avg upside 32 analysts	$64.00 11.67% Downside	-12.4%
AVR Anteris Technologies Global Corp.	May 15, 2026	BUY	Strong Buy +49.3% avg upside 5 analysts	$18.00 84.13% Upside	+19.1%
JNJ Johnson & Johnson	May 13, 2026	HOLD	Strong Buy -3.5% avg upside 36 analysts	$255.00 11.59% Upside	-0.3%
HUMA Humacyte	May 13, 2026	BUY	Strong Buy +665.4% avg upside 11 analysts	$1.50 62.27% Upside	-6.6%
OBIO Orchestra BioMed Holdings	May 13, 2026	BUY	Strong Buy +232.1% avg upside 9 analysts	$13.00 225.72% Upside	+1.2%
BDX Becton Dickinson	May 11, 2026	BUY	Buy +35.5% avg upside 25 analysts	$204.00 41.75% Upside	+1.3%
SENS Senseonics Holdings	May 11, 2026	BUY	Buy +124.8% avg upside 13 analysts	$31.00 360.00% Upside	+0.0%
GMED Globus Medical	May 11, 2026	BUY	Strong Buy +21.0% avg upside 24 analysts	$123.00 55.27% Upside	+4.8%
TNDM Tandem Diabetes Care	May 08, 2026	BUY	Buy +116.0% avg upside 29 analysts	$55.00 259.49% Upside	+9.2%
INMD InMode	May 07, 2026	BUY	Buy +41.7% avg upside 9 analysts	$19.00 41.69% Upside	-4.0%
LIVN LivaNova	May 07, 2026	HOLD	Strong Buy +0.2% avg upside 14 analysts	$76.00 3.10% Downside	-1.3%
CH:ALC Alcon	May 06, 2026	HOLD	Buy +33.9% avg upside 35 analysts	$62.78 18.75% Upside	·
ATEC Alphatec Holdings	May 06, 2026	BUY	Strong Buy +112.9% avg upside 22 analysts	$24.00 172.52% Upside	+15.7%
BAX Baxter International	May 04, 2026	BUY	Hold +49.6% avg upside 23 analysts	$27.00 35.83% Upside	+25.3%
SYK Stryker	May 01, 2026	BUY	Strong Buy +24.0% avg upside 36 analysts	$394.00 28.02% Upside	+3.0%
GEHC GE Healthcare Technologies Inc	Apr 30, 2026	HOLD	Strong Buy +36.0% avg upside 20 analysts	$78.00 26.66% Upside	+1.2%
BLCO Bausch + Lomb Corporation	Apr 30, 2026	HOLD	Buy +30.8% avg upside 19 analysts	$20.00 34.59% Upside	-4.5%
ZBH Zimmer Biomet Holdings	Apr 29, 2026	SELL	Buy +27.6% avg upside 37 analysts	$94.00 6.90% Upside	-10.8%
EW Edwards Lifesciences	Apr 24, 2026	BUY	Strong Buy +11.7% avg upside 34 analysts	$110.00 25.96% Upside	+3.0%
ISRG Intuitive Surgical	Apr 23, 2026	BUY	Strong Buy +29.4% avg upside 36 analysts	$651.00 60.01% Upside	-15.0%
ABT Abbott Laboratories	Apr 20, 2026	BUY	Strong Buy +31.2% avg upside 35 analysts	$143.00 61.77% Upside	-7.8%
MDT Medtronic	Apr 01, 2026	BUY	Buy +23.5% avg upside 38 analysts	$120.00 51.34% Upside	-7.8%
MMED MiniMed Group, Inc.	Mar 31, 2026	BUY	Strong Buy +47.2% avg upside 13 analysts	$26.00 76.12% Upside	·
COO Cooper Co	Mar 24, 2026	BUY	Buy +102.3% avg upside 21 analysts	$103.00 56.17% Upside	-4.5%
ORGO Organogenesis Holdings	May 11, 2022	BUY	Strong Buy +375.4% avg upside 8 analysts	$25.00 924.53% Upside	-51.0%
ALGN Align Tech	May 04, 2022	BUY	Strong Buy +56.4% avg upside 21 analysts	$418.00 129.48% Upside	-2.2%
RBOT Vicarious Surgical	Mar 04, 2022	BUY	Buy +5334.8% avg upside 6 analysts	$13.00 5552.19% Upside	·
SDCCQ SmileDirectClub	Mar 03, 2022	BUY	Sell +513999900.0% avg upside 10 analysts	$20.00 1999999899.96% Upside	-74.5%
SHC Sotera Health	Mar 02, 2022	BUY	Strong Buy +29.6% avg upside 13 analysts	$28.00 77.05% Upside	-13.1%
XRAY DENTSPLY SIRONA	Mar 01, 2022	BUY	Buy +170.6% avg upside 25 analysts	$67.00 548.62% Upside	-30.3%
HSIC Henry Schein	Feb 16, 2022	BUY	Buy +7.4% avg upside 25 analysts	$100.00 25.10% Upside	-1.7%
IART Integra Lifesciences	Nov 03, 2021	BUY	Buy +136.2% avg upside 21 analysts	$87.00 394.93% Upside	-32.3%
NVST Envista Holdings	Sep 30, 2021	BUY	Buy +12.8% avg upside 19 analysts	$55.00 112.21% Upside	-21.5%
MDXG MiMedx Group	Dec 12, 2016	SELL	Strong Buy +184.1% avg upside 17 analysts	$9.00 145.27% Upside	-34.5%
HIND Vyome Holdings	Oct 31, 2016	BUY	Strong Buy +1351.6% avg upside 8 analysts	$21.00 867.66% Upside	-34.8%
SNN Smith & Nephew Snats	Nov 03, 2014	HOLD	Buy +11.8% avg upside 14 analysts	$37.00 22.96% Upside	+3.5%
CNMD Conmed	Jul 24, 2013	HOLD	Hold +81.2% avg upside 12 analysts	$36.00 10.46% Upside	+19.7%
OFIX Orthofix Medical	Mar 14, 2013	HOLD	Strong Buy +207.1% avg upside 15 analysts	$43.00 354.98% Upside	-35.4%

🔒 35 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Matt Miksic — Frequently Asked Questions

How accurate are Matt Miksic's stock ratings?

Based on the calls 13Foresight could measure, about 34% of Matt's ratings were profitable over a one-year hold, with an average return of -9.3% per rating, or -12.7% versus the S&P 500. We score every analyst the same way, from historical prices.

How is Matt ranked on 13Foresight?

Matt Miksic is currently ranked #2281 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Matt cover?

Matt most recently has ratings on BSX, PODD, DXCM, AVR, JNJ, HUMA, OBIO, BDX, SENS, GMED, TNDM, INMD and 28 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Rating Distribution

Welcome to 13Foresight!